I. INTRODUCTION
Rheumatoid arthritis (RA) is a chronic inflammatory disease that affects joints and synovium. Extra-articular manifestation of RA such as subcutaneous nodules, pulmonary fibrosis, and peripheral neuropathy is seen in up to 10-20 % of patients. Subclinical carpal tunnel syndrome (CTS) had been described in RA with a pooled prevalence of 14% [1] .
Entrapment neuropathy result in a distal sensory, or in a combined sensory and sensorimotor neuropathy [2] - [4] .CTS is the most common form of entrapment neuropathies, which occur because of acute or chronic compressive injury of the median nerve at the wrist. Tenosynovial proliferation of the flexor tendons, joint erosions and ligamentous laxity result in loss of carpal tunnel height and increases pressure in the carpal tunnel [1] - [4] , results in compression of the median nerve and vessels in the perineurium causing median nerve ischemia and CTS in RA [4] . Other mechanisms found to contribute to CTS development in RA are drug toxicity, vasculitis and amyloidosis [5] .lately numerous studies demonstrated that ultrasound is valuable diagnosing tool for CTS diagnosis [6] .
In this study, we aimed to investigate the median nerve cross sectional area (MNCSA) in patients with RAwho have no symptoms or signs of CTS, and never been diagnosed to have CTS. We looked at the effect of the RA clinical characteristics, inflammatory markers and renal parameters on the MNCSA.
II. SUBJECTS AND METHODS

A. STUDY PARTICIPANTS
Patients with RA (120 patients) recruited from May 2012 till December 2016,through a specialized rheumatology clinic.
All the patients gave written consent according to the Declaration of Helsinki, and the study was approved by the Central Research Ethics Committee of our health institute.
B. CLINICAL ASSESMENT
RA was defined according to the revised criteria of the American College of Rheumatology [7] . All the Clinical evaluation was carried out by one rheumatologist (SH).
Patients with thyroid, diabetes mellitus, renal, liver disease, pregnant women, gout and history of peripheral neuropathy, current symptoms of CTS and history of previous carpal tunnel release were excluded from the study.
Age, gender, alcohol and smoking consumption(current/past smoking, duration of smoking and number of cigarettes per day) were assessed with standardized patient assessment form. Also, patients were questioned about symptoms suggestive of the CTS or any neuropathy in other distribution.
Past medical history was obtained by reviewing doctors' electronic charts including RA duration, age at RA symptoms onset, presence of rheumatoid factor (RF), rheumatoid level (NR: 0.0-morbidities (i.e. Diabetes, thyroid diseases, renal and liver diseases, previous carpal tunnel release and gout). Gout was defined as either use of hypouricemic agents or clinical diagnosis.
The patients underwent detailed physical examination and laboratory investigations before ultrasound (US) measurement. Systolic blood pressure (SBP) and diastolic blood pressure (DBP)) measured in the right upper arm of patients in a seated position using an automatic oscillometric blood pressure recorder. Patients were examined for joints tenderness and swelling.Neurological examination was performed with standard assessment including muscle strength, sensory testing (light touch, pinprick, position, temperature, and vibration sense). Patients were examined for the presence of Tinel's sign, Phalen test, thenaratrophy and Flick sign.Standing height and weight were measured.
A fasting blood sample was obtained for measurement of [8] .
Score for the Disease Activity Score-28 joints (DAS-28) was calculated usingESR.BMI was calculated using the formula of weight in kilograms divided by height in meters. Glomerular Filtration Rate (GFR) calculated using Modification of Diet in Renal Disease (MDRD) formula.
C. MNCSA ULTRASOUND (US) MEASURMENTS
All the MNCSA US measurements were performed bilaterally on all patients by one qualified sonographer. Patients were lying on the bed on a supine position, with their forearm in a supinated resting position on a small table. The US probe (an 8-16 MHz linear array transducer) was held as lightly as possible to not disturb the anatomy of the nerve. The median nerve was examined at the entrance of the carpal tunnel, between the pisiform bone and tubercle of the navicular, for which the distal volar crease is an external landmark. The cross-sectional area of the median nerve was calculated directly by the software of the US equipment. Each median nerve was examined three times, and the mean value was used in further calculations.
During the inclusion of RA participants for this study, 9 % were excluded because of division of their median nerve at the entrance of the carpal tunnel; that is 12 out of 132 patients, left with 120 patients.
III. STATISTICAL ANALYSIS
Summary statistical analysis results were expressed as percentages for categorical data and mean ± standard deviation (SD) for continuous variables. The correlation between MNCSA and other variables were calculated using simple linear regression analysis with MNCSA as a dependent variable. Covariates were renal function parameters, traditional cardiovascular risk factors, and inflammatory markers. P value of less than 0.05 were accepted as statistically significant. Multivariate model included all the variables that were significantly related to the MNCSA in the univariate models. All statistics were performed using STATA program.
IV. RESULTS
All the participants were free of thyroid, diabetes mellitus, renal, liver disease, pregnancy, gout, history of peripheral neuropathy, current symptoms of CTS and history of previous carpal tunnel release.
A. STUDY PARTICIPANTS, RA CLINICAL CHARACTERITICS AND INFLAMMATORY MARKERS
The study included 240 hands of120 rheumatoid arthritis patients (104 females (87%), and 16 (13%)males. Average age was49 ± 13 years. 92 (77 %) patients were rheumatoid factor seropositive. The mean duration of rheumatoid arthritis was 77 ±107 months. The mean ESR was 33±24 mm/hr, mean CRP was 9.4±17 mg/dl. The average GFR was 124±34 ml/min (62-286).The demographic and the clinical characteristics of RApatients are displayed in table 1.
B. MEDIAN NERVE THICKNESS
Then mean MNCSA among our study participants was 9.79 ±2.6.mm 2 (range 1.5 -22.25). The MNCSA was positively associated with the age of participants (p=0.03, CI: 0.00, 0.08), BMI (p=0.04, CI: 0.00, 0.21), SUA (p= 0.033, CI:0.00, 0 .01), and urine microalbumin (p=0.04, CI: 0.00, 0.01). GFR level, inflammatory markers (ESR and CRP) and other RA disease activity markers showed no significant relation to the MNCSA.
Multiple regression analysis that included age, sex, renal parameters and inflammatory markers, showed a persistence significant positive relationship of the age of the participants to the MNCSA (p= 0.03, CI: 0.003, 0.011).
V. DISCUSSION
Rheumatoid arthritis is associated with autonomic and entrapment neuropathy resulting in distal sensory or combined sensory-motor neuropathy [9] , [10] .
Carpal tunnel syndrome is the most common upper limb entrapment neuropathy in the general population and in RA [11] , [12] caused by compression of the median nerve in the carpal tunnel beneath the flexor retinaculum. The existence of subclinical neuropathy can be achieved by electro-diagnostic studies and by ultrasound [13] .
As no previous study looked at the determinants of the cross-sectional area of the median nerve in patients with arthritis with no carpal tunnel syndrome. This study,provided data about MNCSA in RA patients and itsrelation to the inflammatory markers and renal function in rheumatoid arthritis patients, provide a new paradigm for further future studies in this field.
A. MEDIAN NERVE AND ULTRA-SONOGRAPHIC ASSESSMENT
US has been found to be a precise method to display the anatomy of the median nerve [11] ., and several studies have shown that US have high sensitivity and specificity for the diagnosis of idiopathic CTS [14] - [17] .More, evaluation of the median nerve by assessing cross sectional area at the wrist inlet had been found as a sensitive and specific test in RA and in general population [18] .
B. MNCSA AND CTS SYMPTOMS
In general practice 10 mm 2 MNCSA is used as a cutoff value [19] , [20] .Increased MNCSA is highly correlated with CTS clinical symptoms [21] , [22] . CSA of 10-13 mm 2 have been reported in patients with mild symptoms [6] ., and could raise the suspicion of CTS in patients with RA [23] . RA patients without symptoms or signs of CTS have same MNCSA as healthy controls [13] . This is in consistence with the MNCSA in our patients who had no symptoms or clinical sings of CTS. However, unlike our study, they did not look at the determinants of MNCSA in RA population. www.wjrr.org
C. MNCSAAND THE RA CLINICAL CHARACTERISTICS AND INFLAMMTORY ACTIVITIES
Previous studies showed that in healthy individual, the MNCSA at the level of entrance into the carpal tunnel has the highest diagnostic sensitivity and specificity for CTS. Normal range of the MNCSA is between 7.0 ± 1.0 mm 2 and 10.2 ± 2.5 mm 2 [15] - [17] . The range of the MNCSA in our study participants was found to be within the reported normal range. This is of no surprise considering that mean MNCSA in RA patients without signs and symptoms of CTS found to be like healthy control in a previous study with no significant relationship between the median nerve involvement and clinical or laboratory parameters in RA [1] . This is consistentwith our findings that no RA clinical characteristicsor inflammatoryactivities markers has a relation to the MNCSA. However, othersfound a significant association between RA disease duration and the occurrence of CTS [23], [24] .Karadag et al disclosed that age, disease duration and functional scores were higher among the RA patients with CTS [23] . The mean duration of RA in our study is 77 months and may be this time is not sufficient for RA patients to develop CTS. Additional explanation for the normal range of the MNCSA in our study might be attributed to the young average age of the participants. 
D. MEDIAN NERVE CSA AND THE AGE OF THE PARTICIPANTS
E. MNCSA ANDBMI
The data of the relationship between the MNCSA and the body weight is not consistence. Although some studies showed that obesity does not influence carpal canal pressure or the size of the median nerve at the wrist. Others reported a strong association between slowed median nerve conduction and increased nerve size in individuals with BMI of more than 29. BMI> 29 is associated with 2.5 times more risk of CTS compares to individual with BMI<20 [29] .
Our results of a positive linear relationship between MNCSA and the BMIis agreeing with the findings of Werner et al [29] ., and contradictory to Hammer et al, who found a relationship between the cross-sectional areas of the median nerves and height and weight in healthy controls, but not in RA patients [13] . However,Hammer et alprovided no reasons for the discrepancy.Hammer et al suggested that their finding implies that neither height nor weight should be considered to have a major impact on the evaluation of the measured area of the median nerve in an RA patient [13] . From public health prospective, this unlikely to be right.
F. MEDIAN NERVE CSA AND MICROALBUMINURIA
Microalbuminuria is defined as urinary excretion of albumin that is persistently increased above normal but below the sensitivity of conventional semi quantitative test strips. Microalbuminuria is a sign of glomerular dysfunction in general and to a lesser extent a sign of tublointerstitial disease [30] .
Among diabetic patient, median nerve motor conduction velocity was significantly slower, and CTS is higher in microalbuminuric (48.4(1.4) m/s) than in normoalbuminuric (52.7(1.2) m/s, p = 0.04) [31] . In the view of absence of previous studies to examine the MNCSA and mircroalbuminruia in RA setting, our study is the first to report a significant association between MNCSA and microalbuminuria, in a similar fashion to what had been reported in the diabetic population.
VI. LIMITATION AND STRENGTH
This study is limited by our failure to control for participants occupations which may contribute to the development of CTS.
The strength of our study is in the fact that we excluded patients with diseases that might affect the MNCSA (such as diabetes, thyroid dysfunction, renal and liver diseases, gout and pregnancy). The study also excluded patients with CTS symptoms/clinical sings and those who had a previous history of carpal tunnel release. Also, the US assessment carried out in our study was the cross-sectional area at the entrance of the carpal tunnel which had been reported to have the highest sensitivity and specificity for CTS [[14] - [17] . 
